Clinical Trial Update: Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA [Phase 1]

View source ↗

Summary

Phase 1 dose-evaluation safety study of PolyMVA in individuals with glioblastoma multiforme (grade IV astrocytoma) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Poly-MVA

Snippet

Sponsor: Stony Brook University | Conditions: Glioblastoma Multiform (Grade IV Astrocytoma) | Phase 1 | Status: COMPLETED